31P-MRS
Showing 1 - 25 of >10,000
Analysing Peripheral Skeletal Muscle Function Before and After
Not yet recruiting
- Emphysema
- 31P-Magnetic Resonance Spectroscopy (31P-MRS)
- (no location specified)
Sep 6, 2023
MDD Trial (Low Dose 5-hydroxytryptophan, High Dose 5-hydroxytryptophan, Low Dose Creatine Monohydrate)
Not yet recruiting
- Major Depressive Disorder
- Low Dose 5-hydroxytryptophan
- +4 more
- (no location specified)
Jun 8, 2023
Amyotrophic Lateral Sclerosis Trial in Dallas (Gold Nanocrystals)
Withdrawn
- Amyotrophic Lateral Sclerosis
- Gold Nanocrystals
-
Dallas, TexasUT Southwestern
Jan 11, 2022
Relapsing Remitting Multiple Sclerosis Trial in Dallas (gold nanocrystals)
Recruiting
- Relapsing Remitting Multiple Sclerosis
- gold nanocrystals
-
Dallas, TexasUniversity of Texas Southwestern
Jan 11, 2022
Parkinson's Disease Trial in Dallas (Gold Nanocrystals)
Completed
- Parkinson's Disease
- Gold Nanocrystals
-
Dallas, TexasUT Southwestern
Nov 18, 2021
MDD Trial in Salt Lake City (5-Hydroxytryptophan 100 MG, Creatine monohydrate, matched to 5-HTP)
Recruiting
- Major Depressive Disorder
- 5-Hydroxytryptophan 100 MG
- +3 more
-
Salt Lake City, UtahUniversity of Utah Department of Psychiatry
Apr 27, 2021
Mitochondrial dysfUnction:Key Player in Doxorubicin-induced
Not yet recruiting
- Doxorubicin Induced Cardiomyopathy
- +3 more
- 31-MRS at 7 Tesla (T)
-
Utrecht, Netherlands
- +1 more
Feb 7, 2023
Diabetes, Type 2, Diabetic Cardiomyopathies Trial in Maastricht (31P-MRS scan and cardiac MRI scan, Atrial biopsy for
Completed
- Diabetes Mellitus, Type 2
- Diabetic Cardiomyopathies
- 31P-MRS scan and cardiac MRI scan
- +4 more
-
Maastricht, Limburg, NetherlandsHuman Biology
Nov 3, 2020
Physical Activity Trial (Isometric Contraction Exercise - Young Adults (Age group 18-39), Isometric Contraction Exercise -
Recruiting
- Physical Activity
- Isometric Contraction Exercise - Young Adults (Age group 18-39)
- +2 more
-
Baton Rouge, LouisianaPennington Biomedical Research Center
Sep 26, 2022
Pompe Disease -Non-invasive Magnetic Resonance Exploratory Pilot
Not yet recruiting
- Pompe Disease
- McArdle Disease
- Siemens Magnetom 7T Plus
-
Vienna, AustriaMedical University of Vienna
Jul 5, 2023
Heart Failure With Reduced Ejection Fraction, Heart Failure Trial in Groningen (Ketone ester drink (DeltaG®, 500 mg/kg body
Enrolling by invitation
- Heart Failure With Reduced Ejection Fraction
- Heart Failure
- Ketone ester drink (DeltaG®, 500 mg/kg body weight)
- Taste-matched, isovolumic placebo drink
-
Groningen, NetherlandsUniversity Medical Center Groningen
Apr 20, 2022
HF - Heart Failure, Iron-deficiency Trial in Groningen (31Phosphor Magnetic Resonance Spectroscopy)
Enrolling by invitation
- HF - Heart Failure
- Iron-deficiency
- 31Phosphor Magnetic Resonance Spectroscopy
-
Groningen, NetherlandsUMCG
Feb 27, 2023
Magnetic Resonance & Optical Spectroscopy Validation
Recruiting
- Validation Studies
- Magnetic Resonance Spectroscopy
-
Orlando, FloridaTranslational Research Institute for Metabolism and Diabetes
Apr 12, 2022
Alzheimer, Dementia Trial in Bergen (Placebo, Nicotinamide Riboside supplementation 1000mg daily in total, Nicotinamide Riboside
Recruiting
- Alzheimer Disease
- Dementia
- Placebo
- +2 more
-
Bergen, Vestland, Norway
- +1 more
Nov 25, 2022
Parkinson Disease Trial in Bergen (Nicotinamide Riboside, Placebo)
Recruiting
- Parkinson Disease
- Nicotinamide Riboside
- Placebo
-
Bergen, Vestland, NorwayHaukeland University Hospital
Nov 28, 2022
Prehabilitation, Surgery, Exercise Prehabilitation Trial in Groningen (exercise MRI)
Not yet recruiting
- Prehabilitation
- +3 more
- exercise MRI
-
Groningen, NetherlandsUniversity Medical Center Groningen
Mar 6, 2023
Peripheral Artery Disease (spectroAMI)
Recruiting
- Arterial Occlusive Diseases
- Magnetic Resonance Imaging (MRI)
-
Saint-Étienne, FranceChu Saint-Etienne
Nov 16, 2021
Muscular Deficits of Diabetic Myopathy
Recruiting
- Diabetes Mellitus
- +5 more
- 6-months of medically assisted glycemic improvement
- Bariatric surgery
-
Aarhus, DenmarkAarhus University Hospital, Denmark
Jan 5, 2023
Healthy Trial in Bergen (nicotinamide riboside, nicotinamide mononucleotide)
Recruiting
- Healthy
- nicotinamide riboside
- nicotinamide mononucleotide
-
Bergen, Vestland, NorwayHaukeland University Hospital
Jan 25, 2023
Type 2 Diabetes, Diabetic Cardiomyopathies, HFpEF - Heart Failure With Preserved Ejection Fraction Trial in Oxford (IMB-1018972)
Recruiting
- Type 2 Diabetes
- +2 more
-
Oxford, United KingdomOxford University Hospital
Jan 9, 2023
Aging, Metabolism Disorder, Ketonemia Trial in Aarhus (D-ß-hydroxybutyrate/D 1,3 butanediol monoester)
Recruiting
- Aging
- +3 more
- D-β-hydroxybutyrate/D 1,3 butanediol monoester
-
Aarhus, Aarhus N, DenmarkSteno Diabetes Center Aarhus
Feb 8, 2023
Bipolar I Disorder, Depression, Anxiety, Stress Trial (Magnesium vitamin B6, Placebo)
Not yet recruiting
- Bipolar I Disorder
- +2 more
- Magnesium vitamin B6
- Placebo
- (no location specified)
Apr 28, 2023
Huntington Disease Trial in Paris, Leiden (Triheptanoin oil, Placebo)
Completed
- Huntington Disease
- Triheptanoin oil
- Placebo
-
Paris, France
- +1 more
Aug 24, 2021
Exercise Intolerance in Heart Failure
Recruiting
- Heart Failure With Normal Ejection Fraction
-
Baltimore, MarylandJohns Hopkins Hospital
Aug 26, 2022
Basic Science Trial in Lausanne (Peptamen® 1.5 Vanilla, Boost Plus® Vanilla)
Completed
- Basic Science
- Peptamen® 1.5 Vanilla
- Boost Plus® Vanilla
-
Lausanne, SwitzerlandÉcole Polytechnique Fédérale de Lausanne (EPFL) / Center for Bio
Dec 4, 2018